Have a personal or library account? Click to login
Gut microbiota disorders and ophthalmic diseases Cover
Open Access
|Mar 2026

References

  1. Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J 2017;474(11):1823-36. doi: 10.1042/BCJ20160510.
  2. Ling Z, Liu X, Cheng Y, Yan X, Wu S. Gut microbiota and aging. Crit Rev Food Sci Nutr 2022;62(13):3509-34. doi: 10.1080/10408398.2020.1867054.
  3. Jethwani P, Grover K. Gut microbiota in health and diseases – a review. Int J Curr Microbiol Appl Sci 2019;8(8):1586-99.
  4. Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek 2020;113(12):2019-40.
  5. Zhu S, Jiang Y, Xu K, Cui M, Ye W, Zhao G, et al. The progress of gut microbiome research related to brain disorders. J Neuroinflammation 2020;17(1):25. doi: 10.1186/s12974-020-1705-z.
  6. Wang Q, Yang Q, Liu X. The microbiota–gut–brain axis and neurodevelopmental disorders. Protein Cell 2023;14(10):762-75. doi: 10.1093/procel/pwad026.
  7. Jesus LB, Hernandez RA, Martinez PA, Suarez VP, Garcia GO, Diaz E, et al. The relationship between gut microbiome and ophthalmologic diseases: a comprehensive review. Cureus 2024;16(8):e66808. doi: 10.7759/cureus.66808.
  8. Shivaji S. A systematic review of gut microbiome and ocular inflammatory diseases: are they associated? Indian J Ophthalmol 2021;69:535-42.
  9. Scuderi G, Troiani E, Minnella AM. Gut microbiome in retina health: the crucial role of the gut–retina axis. Front Microbiol 2022;12:726792. doi: 10.3389/fmicb.2021.726792.
  10. Campagnoli LIM, Varesi A, Barbieri A, Marchesi N, Pascale A. Targeting the gut–eye axis: an emerging strategy to face ocular diseases. Int J Mol Sci 2023;24:13338. doi: 10.3390/ijms241713338.
  11. Lin P, McClintic SM, Nadeem U, Skondra D. A review of the role of the intestinal microbiota in age-related macular degeneration. J Clin Med 2021;10:2072. doi: 10.3390/jcm10102072.
  12. Loh JS, Mak WQ, Tan LKS, Ng CX, Chan HH, Yeow SH, et al. Microbiota– gut–brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 2024;9(1):37. doi: 10.1038/s41392-024-01743-1.
  13. Westaway JAF, Huerlimann R, Kandasamy Y, Miller CM, Norton R, Staunton KM, et al. The bacterial gut microbiome of probiotic-treated very-preterm infants. Pediatr Res 2022;92(1):142-50. doi: 10.1038/s41390-021-01738-6.
  14. Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015;17(5):690-703. doi: 10.1016/j. chom.2015.04.004.
  15. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol 2015;21(29):8787-803. doi: 10.3748/wjg.v21.i29.8787.
  16. Zysset-Burri DC, Keller I, Berger LE, Largiadèr CR, Wittwer M, Wolf S, et al. Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration. NPJ Genom Med 2020;5:34. doi: 10.1038/s41525-020-00141-0.
  17. Xiao J, Zhang JY, Luo W, He PC, Skondra D. The emerging role of gut microbiota in age-related macular degeneration. Am J Pathol 2023;193(11):1627-37.
  18. Andriessen EM, Wilson AM, Mawambo G, Dejda A, Miloudi K, Sennlaub F, et al. Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization. EMBO Mol Med 2016;8(12):1366-79. doi: 10.15252/emmm.201606390.
  19. Parekh Z, Xiao J, Mani A, Evans Q, Phung C, Barba HA, et al. Fecal microbial profiles and short-chain fatty acid/bile acid metabolomics in patients with age-related macular degeneration: a pilot study. Invest Ophthalmol Vis Sci 2025;66(4):21. doi: 10.1167/iovs.66.4.21.
  20. Skondra D, Rodriguez SH, Sharma A, Gilbert J, Andrews B, Claud EC. The early gut microbiome could protect against severe retinopathy of prematurity. J AAPOS 2020;24(4):236-8.
  21. Zhang JY, Greenwald MJ, Rodriguez SH. Gut microbiome and retinopathy of prematurity. Am J Pathol 2023;193(11):1683-90.
  22. Lai MY, Chang YH, Lee CC, NEMO Study Group, Chiu CH, Chiang MC, et al. The impact of gut microbiota on morbidities in preterm infants. Kaohsiung J Med Sci 2024;40(9):780-8.
  23. Modrzejewska M, Bosy-Gąsior W, Grzesiak W. Association of Positive Bacterial Cultures with Severe Retinopathy of Prematurity. J Clin Med 2023;12(19):6374.
  24. Hellström A, Smith LEH, Hård AL. ROP: 80 years after its detection. Neonatology 2024;121(5):608-15. doi: 10.1159/000538907.
  25. Modrzejewska M, Nazwalska M. The long-term observation of the beneficial effects of treatment: 0.12 mg anti-VEGF monotherapy or anti-VEGF combined therapy and diode-laser in various stages of retinopathy of prematurity – series of cases. J Clin Med 2023;12(17):5644. doi: 10.3390/jcm12175644.
  26. Chen H, Cho KS, Vu TK, Shen CH, Kaur M, Chen G. Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nature communications 2018; 9(1): 3209
  27. Rowan S, Jiang S, Korem T, Szymanski J, Chang ML, Szelog J, et al. Involvement of a gut–retina axis in protection against dietary glycemia-induced age related macular degeneration. Proc Natl Acad Sci USA 2017;114:E4472-81.
  28. Zhang Y, Zhou X, Lu Y. Gut microbiota and derived metabolomic profiling in glaucoma. Front Cell Infect Microbiol 2022;12:968992.
  29. Gong H, Zhang S, Li Q, Zuo C, Gao X, Zheng B, et al. Gut microbiota compositional profile and serum metabolic phenotype in glaucoma. Exp Eye Res 2020;191:107921.
  30. Chen S, Wang Y, Liu Y, Li F, Chen Y, Fang X, et al. Dysbiosis of gut microbiome contributes to glaucoma pathogenesis. MedComm Future Med 2022;1:e28.
  31. Ullah Z, Tao Y, Mehmood A, Huang J. The role of gut microbiota in the pathogenesis of glaucoma. Bioengineering 2024;11:1063. doi: 10.3390/bioengineering11111063.
  32. Jiao J, Yu H, Yao L, Li L, Yang X, Liu L. Recent insights into the role of gut microbiota in diabetic retinopathy. J Inflamm Res 2021:6929-38. doi: 10.2147/JIR.S336148.
  33. Huang Y, Wang Z, Ma H, Ji S, Chen Z, Cui Z, et al. Dysbiosis and implication of the gut microbiota in diabetic retinopathy. Front Cell Infect Microbiol 2021;11:646348.
  34. Hou J, Lv Z, Wang Y, Chen D. The gut microbiota regulates diabetic retinopathy in adult rats. Front Microbiol 2025;16:1479792. doi: 10.3389/fmicb.2025.1479792.
  35. Huang Y, Wang Z, Ye B, Ma JH, Ji S, Sheng W, et al. Sodium butyrate ameliorates diabetic retinopathy in mice. J Transl Med 2023;21:451.
  36. Zhao Y, Qiu P, Shen T. Gut microbiota and eye diseases: A review. Medicine 2024;103(39):e39866.
  37. Kodati S, Sen HN. Uveitis and the gut microbiota. Best Pract Res Clin Rheumatol 2019;33(6):101500. doi: 10.1016/j.berh.2020.101500.
  38. Horai R. Gut microbiota linked to autoimmune uveitis. Ann Eye Sci 2017;2:19. doi: 10.21037/aes.2017.03.02.
  39. Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, et al. HLAB27 and human Β2-microglobulin affect the gut microbiota of transgenic rats. PLoS One 2014;9:e105684.
  40. Mi Y, Chen L, Liao N, Wan M. Mendelian randomization analysis revealed a gut microbiota-eye axis in acute anterior uveitis. Eye (Lond) 2025;39(8):1562-70. doi: 10.1038/s41433-025-03715-3.
  41. Nakamura YK, Metea C, Karstens L, Asquith M, Gruner H, Moscibrocki C, et al. Gut microbial alterations associated with protection from autoimmune uveitis. Invest Ophthalmol Vis Sci 2016;57:3747-58.
DOI: https://doi.org/10.21164/pomjlifesci.1140 | Journal eISSN: 2719-6313 | Journal ISSN: 2450-4637
Language: English
Page range: 16 - 21
Published on: Mar 3, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Wiktoria Bosy-Gąsior, Monika Modrzejewska, published by Pomeranian Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.